{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:18:49Z","timestamp":1790716729948,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jinf.2012.09.014","type":"journal-article","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T15:16:41Z","timestamp":1349536601000},"page":"75-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort"],"prefix":"10.1016","volume":"66","author":[{"given":"Sheel","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee Yen","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishan","family":"Wijewardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasiri Rivinda","family":"Vitharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Cormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pakianathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tihana","family":"Bicanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2012.09.014_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2012.09.014_bib2","series-title":"Cryptococcus neoformans: from human pathogen to model yeast","article-title":"Management of cryptocococcal meningoencephalitis in both developed and developing countries","author":"Jarvis","year":"2011"},{"key":"10.1016\/j.jinf.2012.09.014_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome","volume":"337","author":"Van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2012.09.014_bib4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Rate of clearance of infection is independently associated with clinical outcome in HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients","volume":"49","author":"Bicanic","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.09.014_bib5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/605500","article-title":"Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort","volume":"49","author":"Castelnuovo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.09.014_bib6","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1128\/IAI.00542-09","article-title":"Spores as infectious propagules of Cryptococcus neoformans","volume":"77","author":"Velagapudi","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2012.09.014_bib7","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1128\/JCM.37.10.3204-3209.1999","article-title":"Epidemiological evidence for dormant Cryptococcus neoformans infection","volume":"37","author":"Garcia-Hermoso","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2012.09.014_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1 \u2013 infected Ugandan adults","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2012.09.014_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"Jarvis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.09.014_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda","volume":"12","author":"Liechty","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jinf.2012.09.014_bib11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Serum cryptococcal antigen (CRAG) screening is a cost-effective method to prevent death in HIV-infected persons with CD4 \u2264100\/uL starting HIV therapy in resource-limited settings","volume":"51","author":"Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.09.014_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-3156.2010.02683.x","article-title":"Short Communication: low seroprevalence of cryptococcal antigenaemia in patien ts with advanced HIV infection enrolling in an antiretroviral programme in Ghana","volume":"16","author":"Mamoojee","year":"2011","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jinf.2012.09.014_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002030-198902000-00004","article-title":"The value of cryptococcal serum antigen screening among HIV-positive\/AIDS patients in Kinshasa, Zaire","volume":"3","author":"Desmet","year":"1989","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2012.09.014_bib14","unstructured":"Jarvis JN, Harrison T, Lawn S, Meintjes G, Wood R, Cleary S. Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. IAS Rome, 2011, WELBD02-Oral Abstract."},{"key":"10.1016\/j.jinf.2012.09.014_bib15","unstructured":"Govender N. 18th Congress of the International Society for Human and Animal Mycology, Berlin, 11\u201315 June 2012, abstract C3."},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2012.09.014_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1293.2011.00944_3.x","article-title":"Central nervous system opportunistic infections. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011","volume":"12","author":"Nelson","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2012.09.014_bib17","author":"Health Protection Agency"},{"issue":"Suppl","key":"10.1016\/j.jinf.2012.09.014_bib18","first-page":"57","article-title":"Centers for disease control and prevention (CDC). Prevalence of undiagnosed HIV infection among persons aged \u226513 years\u2014National HIV Surveillance System, United States, 2005-2008","volume":"61","author":"Chen","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jinf.2012.09.014_bib19","author":"National Institute of Clinical Excellence"},{"key":"10.1016\/j.jinf.2012.09.014_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2011.00971.x","article-title":"British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011","volume":"13","author":"Asboe","year":"2012","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2012.09.014_bib21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/cid\/cir613","article-title":"Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma and urine from patients with HIV-associated cryptococcal meningitis","volume":"53","author":"Jarvis","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.09.014_bib22","unstructured":"Alpha Laboratories. Crytpcococcal Antigen Systems. Available\u00a0at: www.alphalabs.co.uk\/product-information\/diagnostic-products\/mycology\/cryptococcal-antigen-systems.aspx [accessed 22.06.12]."},{"key":"10.1016\/j.jinf.2012.09.014_bib23","doi-asserted-by":"crossref","unstructured":"Jarvis JN, Govender N, Chiller T, Park BJ, Longley N, Meintjes G, et\u00a0al. Cryptococcal antigen screening and pre-emptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J Int Assoc Physicians AIDS Care (Chic) 2012 Sep 26. [Epub ahead of print].","DOI":"10.1177\/1545109712459077"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312002824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312002824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:17:23Z","timestamp":1759007843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445312002824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0163445312002824"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2012.09.014","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2012.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The British Infection Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}